The lyophilized injectable market size is expected to reach around US$ 5 billion by 2030 from at US$ 2.7 bn in 2020, expanding growth at a CAGR of 5.1% from 2021 to 2030.
Lyophilization is the most commonly used method for the manufacturing of parenteral pharmaceutical products, when the product is unstable in aqueous solution. It is central to the protection of materials, which require low moisture content (less than 1%) in order to ensure stability and require a sterile and gentle preservation process.
Improved quality and shelf life of lyophilized drugs has attracted industry experts to implement lyophilization in their manufacturing processes. Contract research and manufacturing organizations have increased the use of lyophilized injectable drugs to provide quality products to customers. Therefore, rapidly growing contract research manufacturing services (CRAMS) is projected to drive the global lyophilized injectable market.
Lyophilized injectable drugs are stable at ambient temperatures and only require simple rehydration to be ready to use. This removes many sources of pipetting errors, while streamlining and simplifying workflows.
Elimination of the cold chain minimizes costs and carbon footprint, and provides a positive environmental impact by minimizing the need of expanded polystyrene (EPS or ‘Styrofoam’) containers often utilized to ship temperature-controlled products.
Lyophilized products are considered safe for use, while delivering the desired functionality compared to non-lyophilized products. Moreover, lyophilization helps retain the biological and chemical activity of the chemical compound in the final product. This drives the demand for lyophilized injectable drugs in the pharmaceutical and biotechnology industries.
Expansion of Pipeline of Lyophilized Injectable Drugs to Drive Global Market
The continuous research & development to develop innovative drugs for the treatment of chronic diseases has propelled the development of lyophilized injectable drugs in the pharmaceutical industry. Product innovation and acquisition provide key players with the opportunities to penetrate a new therapeutic area/market. About 2,400 injectable products are presently in the development pipeline. This is expected to augment the global lyophilized injectable market.
Development of Alternative Methods to Hamper Market Growth
Lyophilization of injectable drugs is an expensive process. Hence, manufacturers strive to develop alternative drying methods to increase the shelf life of products, which can prove economical. However, such alternative processes need improvement in terms of retaining stability and biological or chemical activity of the substance. Roche has developed a precipitation method as an alternative to lyophilization for the production of peptides, which enabled the company to reduce production costs, and deliver an effective, quality, and affordable product to customers. The advent of alternative methods during the forecast period is likely to hamper the growth of the global lyophilized injectable market.
Single-use Vials Dominated Global Market
The report offers detailed segmentation of the global lyophilized injectable market based on type of packaging, type of delivery, indication, and end user. In terms of type of packaging, the single-use vials segment dominated the global market in 2020. The increase in self-administration of lyophilized injectable drugs to treat various chronic conditions such as diabetes, rheumatoid arthritis, and migraine is projected to drive the single-use vials segment during the forecast period. The specialty packaging segment is expected to grow at a rapid pace from 2021 to 2031, as the segment offers packaging solutions such as pens, needle-free injectors, and two-part syringes that allow reconstitution in the device prior to injection.
Hospitals to be Major End User
In terms of end user, the lyophilized injectable market has been divided into hospitals, ambulatory surgical centers, specialty clinics, and others The hospitals segment is expected to expand at a high CAGR during the forecast period, due to increase in the number of hospitals and high patient preference to visit hospitals for treatment.
North America to Dominate Global Market
The global lyophilized injectable market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global lyophilized injectable market in 2020, followed by Europe. North America accounted for a major share of the global lyophilized injectable market in 2020, due to extensive research & development activities, rapid acceptance of innovative technologies, and significant investments toward the development of healthcare infrastructure. Additionally, presence of a large number of manufacturing facilities in North America makes it the largest market for lyophilized injectable drugs.
Competitive Landscape and Market Share Analysis
The lyophilized injectable market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, lyophilized injectable sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2017-2020, this study provides the lyophilized injectable sales, revenue and market share for each player covered in this report.
The report also presents profiles of leading players in the global lyophilized injectable market. These include B. Braun Melsungen AG, Baxter International, Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, and Jubilant HollisterStier LLC.
Market Segmentation
Market By Type of Packaging
Market By Type of Delivery
Market By Indication
Market By End User
Market By Region
This report focuses on lyophilized injectable market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall lyophilized injectable market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global lyophilized injectable market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the lyophilized injectable market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the lyophilized injectable market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Lyophilized injectable market.
Market Segments: This part of the report discusses about product, application and other segments of the lyophilized injectable market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global lyophilized injectable market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the lyophilized injectable market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
Research Methodology
The research methodology adopted by analysts for compiling the global lyophilized injectable market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global lyophilized injectable market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Lyophilized Injectable Market, By Type of Packaging
7.1. Lyophilized Injectable Market, by Type of Packaging, 2021-2030
7.1.1. Single-use Vials
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Point-of-care Reconstitution
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Specialty Packaging
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Lyophilized Injectable Market, By Type of Delivery
8.1. Lyophilized Injectable Market, by Type of Delivery, 2021-2030
8.1.1. Prefilled Diluent Syringes
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Proprietary Reconstitution Devices
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Single-step Devices
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Multi-step Devices
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Lyophilized Injectable Market, By Indication
9.1. Lyophilized Injectable Market, by Indication, 2021-2030
9.1.1. Autoimmune Diseases
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Metabolic Conditions
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Infectious Diseases
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10.Global Lyophilized Injectable Market, By End User
10.1. Lyophilized Injectable Market, by End User, 2021-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Specialty Clinics
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 11.Global Lyophilized Injectable Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.1.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.1.3. Market Revenue and Forecast, by Indication (2016-2030)
11.1.4. Market Revenue and Forecast, by End User (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.1.5.3. Market Revenue and Forecast, by Indication (2016-2030)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.1.6.3. Market Revenue and Forecast, by Indication (2016-2030)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.2.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.2.3. Market Revenue and Forecast, by Indication (2016-2030)
11.2.4. Market Revenue and Forecast, by End User (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.2.5.3. Market Revenue and Forecast, by Indication (2016-2030)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.2.6.3. Market Revenue and Forecast, by Indication (2016-2030)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.2.7.3. Market Revenue and Forecast, by Indication (2016-2030)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.2.8.3. Market Revenue and Forecast, by Indication (2016-2030)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.3.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.3.3. Market Revenue and Forecast, by Indication (2016-2030)
11.3.4. Market Revenue and Forecast, by End User (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.3.5.3. Market Revenue and Forecast, by Indication (2016-2030)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.3.6.3. Market Revenue and Forecast, by Indication (2016-2030)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.3.7.3. Market Revenue and Forecast, by Indication (2016-2030)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.3.8.3. Market Revenue and Forecast, by Indication (2016-2030)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.4.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.4.3. Market Revenue and Forecast, by Indication (2016-2030)
11.4.4. Market Revenue and Forecast, by End User (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.4.5.3. Market Revenue and Forecast, by Indication (2016-2030)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.4.6.3. Market Revenue and Forecast, by Indication (2016-2030)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.4.7.3. Market Revenue and Forecast, by Indication (2016-2030)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.4.8.3. Market Revenue and Forecast, by Indication (2016-2030)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.5.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.5.3. Market Revenue and Forecast, by Indication (2016-2030)
11.5.4. Market Revenue and Forecast, by End User (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.5.5.3. Market Revenue and Forecast, by Indication (2016-2030)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type of Packaging (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Type of Delivery (2016-2030)
11.5.6.3. Market Revenue and Forecast, by Indication (2016-2030)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2030)
Chapter 12. Company Profiles
12.1. B. Braun Melsungen AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Baxter International Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BD
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Schott AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Aristopharma Ltd.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Vetter Pharma
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Jubilant HollisterStier LLC.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms